InvestorsHub Logo
Followers 3
Posts 1678
Boards Moderated 0
Alias Born 12/23/2011

Re: sal32647 post# 624

Monday, 04/08/2019 8:40:54 AM

Monday, April 08, 2019 8:40:54 AM

Post# of 1471
While nothing in that statement is incorrect, I believe the "market" has already factored that into the PPS and it's outlook toward RWLK. It seems that the feeling is "too little, too late". The longer it drags on with no confirmed approval, the more cash is burned, without production started.
As for the stroke market and the new device. What people have to remember is that although that market is huge, the devices only apply to and can be utilized in a portion of that market, for several reasons. On top of that the patient then has to run the insurance coverage gaunlet, which is a time consuming process. I don't think there will be a sudden, quick acceptance by the insurance industries,(for the 6.0 device) which everyone seems to be using as a catalyst for the stock's PPS. They may come onboard on a case-by-case basis over a few years.
While a PR of CE or FDA approval may cause a spike in PPS, I believe RWLK has A LOT of bailing to keep this ship afloat.

I own shares at $20, $12.50 and $6 (split adjusted), so I hope I am wrong.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RWLK News